131 related articles for article (PubMed ID: 30447928)
1. Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis.
Sauer CM; Myran DT; Costentin CE; Zwisler G; Safder T; Papatheodorou S; Mucci LA
Crit Rev Oncol Hematol; 2018 Dec; 132():66-75. PubMed ID: 30447928
[TBL] [Abstract][Full Text] [Related]
2. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
3. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Liu Y; Chen JQ; Xie L; Wang J; Li T; He Y; Gao Y; Qin X; Li S
BMC Med; 2014 Mar; 12():55. PubMed ID: 24678716
[TBL] [Abstract][Full Text] [Related]
4. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
[TBL] [Abstract][Full Text] [Related]
5. Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis.
Mahmud SM; Franco EL; Aprikian AG
Int J Cancer; 2010 Oct; 127(7):1680-91. PubMed ID: 20091856
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Hurwitz LM; Joshu CE; Barber JR; Prizment AE; Vitolins MZ; Jones MR; Folsom AR; Han M; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):563-569. PubMed ID: 30487131
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and the risk of prostate cancer.
Bosetti C; Talamini R; Negri E; Franceschi S; Montella M; La Vecchia C
Eur J Cancer Prev; 2006 Feb; 15(1):43-5. PubMed ID: 16374228
[TBL] [Abstract][Full Text] [Related]
8. Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.
García Rodríguez LA; González-Pérez A
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):649-53. PubMed ID: 15066932
[TBL] [Abstract][Full Text] [Related]
9. Regular use of aspirin and prostate cancer risk (United States).
Menezes RJ; Swede H; Niles R; Moysich KB
Cancer Causes Control; 2006 Apr; 17(3):251-6. PubMed ID: 16489532
[TBL] [Abstract][Full Text] [Related]
10. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Sørensen HT; Hallas J; Larsen SB; Tjønneland A; Friis S
Cancer Causes Control; 2016 Sep; 27(9):1067-79. PubMed ID: 27503490
[TBL] [Abstract][Full Text] [Related]
11. Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer.
Perron L; Bairati I; Moore L; Meyer F
Int J Cancer; 2003 Sep; 106(3):409-15. PubMed ID: 12845682
[TBL] [Abstract][Full Text] [Related]
12. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Ma Y; Brusselaers N
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
[TBL] [Abstract][Full Text] [Related]
13. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
Corley DA; Kerlikowske K; Verma R; Buffler P
Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
[TBL] [Abstract][Full Text] [Related]
14. Can Aspirin Reduce the Risk of Endometrial Cancer?: A Systematic Review and Meta-analysis of Observational Studies.
Zhang D; Bai B; Xi Y; Zhao Y
Int J Gynecol Cancer; 2016 Jul; 26(6):1111-20. PubMed ID: 27177285
[TBL] [Abstract][Full Text] [Related]
15. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL; Chan JM
Cancer Prev Res (Phila); 2012 Oct; 5(10):1223-8. PubMed ID: 22961777
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Mahmud SM; Tanguay S; Bégin LR; Franco EL; Aprikian AG
Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
Br J Cancer; 2013 Oct; 109(7):1921-5. PubMed ID: 23887604
[TBL] [Abstract][Full Text] [Related]
18. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies.
Verdoodt F; Friis S; Dehlendorff C; Albieri V; Kjaer SK
Gynecol Oncol; 2016 Feb; 140(2):352-8. PubMed ID: 26701413
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
